Lamberti P - Search Results

1

Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.

Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM. Specchio N, et al. Among authors: lamberti p. Epilepsia. 2008 Apr;49(4):663-9. doi: 10.1111/j.1528-1167.2007.01523.x. Epub 2008 Feb 5. Epilepsia. 2008. PMID: 18266754 Free article. Clinical Trial.

2

Elevated homocysteine levels in Parkinson's Disease: is there anything besides L-dopa treatment?

Zoccolella S, dell'Aquila C, Specchio LM, Logroscino G, Lamberti P. Zoccolella S, et al. Among authors: lamberti p. Curr Med Chem. 2010;17(3):213-21. doi: 10.2174/092986710790149774. Curr Med Chem. 2010. PMID: 20214564 Review.

3

A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.

Pezzoli G, Martignoni E, Pacchetti C, Angeleri V, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E, et al. Pezzoli G, et al. Among authors: lamberti p. Neurology. 1995 Mar;45(3 Suppl 3):S22-7. doi: 10.1212/wnl.45.3_suppl_3.s22. Neurology. 1995. PMID: 7715793 Clinical Trial.

4

Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.

Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E, et al. Pezzoli G, et al. Among authors: lamberti p. Mov Disord. 1994 Jul;9(4):431-6. doi: 10.1002/mds.870090409. Mov Disord. 1994. PMID: 7969210 Clinical Trial.

5

[Plasmapheresis in neuromuscular diseases. Personal cases].

Affuso R, Dimonte D, Pagliarulo R, Serlenga L, Simone IL, Specchio LM, Lamberti P. Affuso R, et al. Among authors: lamberti p. Acta Neurol (Napoli). 1989 Apr-Jun;11(2-3):200-10. Acta Neurol (Napoli). 1989. PMID: 2782116 Italian.

6

Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia.

Lamberti P, de Mari M, Iliceto G, Caldarola M, Serlenga L. Lamberti P, et al. Mov Disord. 1993 Apr;8(2):236-7. doi: 10.1002/mds.870080228. Mov Disord. 1993. PMID: 8474501 No abstract available.

7

[Total sleep deprivation in normal humans. Changes in anxiety, depression and aggressiveness and HVA and 5-HIAA levels in the lumbar cerebrospinal fluid].

Genco S, Puca FM, Livrea P, Specchio LM, Lamberti P, Di Reda L, Papagno G. Genco S, et al. Among authors: lamberti p. Boll Soc Ital Biol Sper. 1976 Jun 15;52(11):794-9. Boll Soc Ital Biol Sper. 1976. PMID: 1016631 Italian. No abstract available.

8

Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?

Lamberti P, de Mari M, Iliceto G, Federico F. Lamberti P, et al. Acta Neurol (Napoli). 1992 Aug-Dec;14(4-6):451-4. Acta Neurol (Napoli). 1992. PMID: 1293988

9

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?

Zoccolella S, Lamberti SV, Iliceto G, Santamato A, Lamberti P, Logroscino G. Zoccolella S, et al. Among authors: lamberti sv, lamberti p. Curr Med Chem. 2010;17(28):3253-61. doi: 10.2174/092986710792232012. Curr Med Chem. 2010. PMID: 20666719 Review.

10

Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.

Zoccolella S, Martino D, Defazio G, Lamberti P, Livrea P. Zoccolella S, et al. Among authors: lamberti p. Curr Vasc Pharmacol. 2006 Jul;4(3):237-43. doi: 10.2174/157016106777698414. Curr Vasc Pharmacol. 2006. PMID: 16842141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page